Comparison · Other
SIDE BY SIDE
Compare up to 4 peptides from the Other category. Tick any two or more — mechanism, protocols, side effects, stacking partners, and best $/mg update instantly.
Pick up to 4
Tick any 2–4 peptides from this category. The comparison updates instantly.
4 / 4 selected
- Biohackers interested in metabolism optimization
- Aging individuals curious about muscle maintenance
- Fitness enthusiasts looking for cutting-edge research
- People exploring options for nerve support
- Those interested in cutting-edge research for tissue protection
- Biohackers curious about investigational compounds
- Biohackers curious about sleep optimization
- People exploring stress management strategies
- Researchers interested in sleep and stress hormones
- Researchers studying advanced pain management solutions
- Biohackers interested in natural compounds with strong effects
- People curious about unique, nature-derived substances
- Those looking for well-established weight loss solutions
- Individuals uncomfortable with experimental compounds
- Anyone expecting immediate or guaranteed results
- Anyone seeking a clinically approved treatment
- Individuals looking for a blood cell booster
- People who prefer well-established therapies
- Those looking for a proven sleep aid
- Anyone expecting quick, guaranteed results
- People uncomfortable with experimental compounds
- Anyone without a background in peptide research
- Individuals looking for over-the-counter pain solutions
- Those concerned about the ethical use of animal-derived substances
- Adipocyte size reduction (preclinical)
- NAD and methyl-donor restoration
- Muscle quality in aged models
- Small-fiber neuropathy (clinical investigation)
- Diabetic neuropathy (clinical investigation)
- Tissue protection (preclinical)
- Sleep architecture research
- Stress-axis modulation
- Opioid withdrawal research
- Analgesia research (preclinical)
- μ-receptor selectivity
5-Amino-1MQ is a small-molecule selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in adipose tissue of obese individuals. NNMT consumes SAM and NAD-precursor met…
ARA-290 is an 11-amino-acid linear peptide derived from the helix B domain of erythropoietin (EPO). It binds the innate repair receptor (a heterodimer of EPO receptor and beta common receptor, CD131)…
DSIP is a 9-amino-acid peptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from the cerebral venous blood of sleeping rabbits in 1977. Despite its name, its mechanism remains poorly def…
Dermorphin is a naturally-occurring opioid heptapeptide (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) first isolated from the skin of Phyllomedusa frogs native to South America. It is a highly selective μ-opio…
- Human safety data is extremely limited — no completed clinical trials
- Unknown long-term effects on systemic methylation and NAD metabolism
- Gastrointestinal discomfort reported anecdotally with oral use
- Reported as well-tolerated in Phase 1-2 trials
- Injection-site reactions
- No significant hematologic changes (distinct from full-length EPO)
- Generally well tolerated in published research with minimal adverse events reported
- Mild injection-site reactions (erythema, itching)
- Occasional next-day grogginess or vivid dreams reported anecdotally
- Respiratory depression — a defining risk of potent μ-opioid agonists; can be fatal at supratherapeutic doses
- Sedation, pruritus, constipation, nausea (classic opioid profile)
- Physical dependence and withdrawal with repeated administration
- Pregnancy and lactation (no safety data)
- Active malignancy (NAD/methylation pathways are broadly implicated in cancer biology)
- Concurrent methylation-sensitive medications without clinical oversight
- Pregnancy and lactation
- Active malignancy (EPOR expression on some tumors — theoretical concern)
- Uncontrolled hypertension
- Pregnancy and lactation (no safety data)
- Active psychiatric illness without clinical oversight
- Concurrent sedative-hypnotic use without medical supervision
- Any self-administration outside a controlled research setting
- Pregnancy and lactation
- Personal or family history of opioid use disorder
Think of it as
Think of it as a potential metabolic tune-up.Best for
- Biohackers interested in metabolism optimization
- Aging individuals curious about muscle maintenance
- Fitness enthusiasts looking for cutting-edge research
Probably not for you if…
- Those looking for well-established weight loss solutions
- Individuals uncomfortable with experimental compounds
- Anyone expecting immediate or guaranteed results
Key benefits
- Adipocyte size reduction (preclinical)
- NAD and methyl-donor restoration
- Muscle quality in aged models
Mechanism of action
5-Amino-1MQ is a small-molecule selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in adipose tissue of obese individuals. NNMT consumes SAM and NAD-precursor met…
Typical protocol
Reported side effects
- Human safety data is extremely limited — no completed clinical trials
- Unknown long-term effects on systemic methylation and NAD metabolism
- Gastrointestinal discomfort reported anecdotally with oral use
Contraindications
- Pregnancy and lactation (no safety data)
- Active malignancy (NAD/methylation pathways are broadly implicated in cancer biology)
- Concurrent methylation-sensitive medications without clinical oversight
Best $/mg
Think of it as
Think of it as a bodyguard for your nerves and tissues.Best for
- People exploring options for nerve support
- Those interested in cutting-edge research for tissue protection
- Biohackers curious about investigational compounds
Probably not for you if…
- Anyone seeking a clinically approved treatment
- Individuals looking for a blood cell booster
- People who prefer well-established therapies
Key benefits
- Small-fiber neuropathy (clinical investigation)
- Diabetic neuropathy (clinical investigation)
- Tissue protection (preclinical)
Mechanism of action
ARA-290 is an 11-amino-acid linear peptide derived from the helix B domain of erythropoietin (EPO). It binds the innate repair receptor (a heterodimer of EPO receptor and beta common receptor, CD131)…
Typical protocol
Reported side effects
- Reported as well-tolerated in Phase 1-2 trials
- Injection-site reactions
- No significant hematologic changes (distinct from full-length EPO)
Contraindications
- Pregnancy and lactation
- Active malignancy (EPOR expression on some tumors — theoretical concern)
- Uncontrolled hypertension
Stacks well with
Best $/mg
Think of it as
Think of it as the sandman of sleep research.Best for
- Biohackers curious about sleep optimization
- People exploring stress management strategies
- Researchers interested in sleep and stress hormones
Probably not for you if…
- Those looking for a proven sleep aid
- Anyone expecting quick, guaranteed results
- People uncomfortable with experimental compounds
Key benefits
- Sleep architecture research
- Stress-axis modulation
- Opioid withdrawal research
Mechanism of action
DSIP is a 9-amino-acid peptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from the cerebral venous blood of sleeping rabbits in 1977. Despite its name, its mechanism remains poorly def…
Typical protocol
Reported side effects
- Generally well tolerated in published research with minimal adverse events reported
- Mild injection-site reactions (erythema, itching)
- Occasional next-day grogginess or vivid dreams reported anecdotally
Contraindications
- Pregnancy and lactation (no safety data)
- Active psychiatric illness without clinical oversight
- Concurrent sedative-hypnotic use without medical supervision
Best $/mg
Think of it as
Think of it as nature's ultra-powerful pain reliever.Best for
- Researchers studying advanced pain management solutions
- Biohackers interested in natural compounds with strong effects
- People curious about unique, nature-derived substances
Probably not for you if…
- Anyone without a background in peptide research
- Individuals looking for over-the-counter pain solutions
- Those concerned about the ethical use of animal-derived substances
Key benefits
- Analgesia research (preclinical)
- μ-receptor selectivity
Mechanism of action
Dermorphin is a naturally-occurring opioid heptapeptide (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) first isolated from the skin of Phyllomedusa frogs native to South America. It is a highly selective μ-opio…
Typical protocol
Reported side effects
- Respiratory depression — a defining risk of potent μ-opioid agonists; can be fatal at supratherapeutic doses
- Sedation, pruritus, constipation, nausea (classic opioid profile)
- Physical dependence and withdrawal with repeated administration
Contraindications
- Any self-administration outside a controlled research setting
- Pregnancy and lactation
- Personal or family history of opioid use disorder
Stacks well with
—Best $/mg
For research purposes only. Not medical advice.